Publishing SNP Genotypes of Human Embryonic Stem Cell Lines: Policy Statement of the International Stem Cell Forum Ethics Working Party

Novel methods and associated tools permitting individual identification in publicly accessible SNP databases have become a debatable issue. There is growing concern that current technical and ethical safeguards to protect the identities of donors could be insufficient. In the context of human embryonic stem cell research, there are no studies focusing on the probability that an hESC line donor could be identified by analyzing published SNP profiles and associated genotypic and phenotypic information. We present the International Stem Cell Forum (ISCF) Ethics Working Party’s Policy Statement on “Publishing SNP Genotypes of Human Embryonic Stem Cell Lines (hESC)”. The Statement prospectively addresses issues surrounding the publication of genotypic data and associated annotations of hESC lines in open access databases. It proposes a balanced approach between the goals of open science and data sharing with the respect for fundamental bioethical principles (autonomy, privacy, beneficence, justice and research merit and integrity).

• Publication year

  2011

• Venue

  Stem Cell Reviews and Reports

• Publication date

  2011-01-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12015-010-9226-2PMID 21279481PMCID 3137773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Public Access to Genome-Wide Data: Five Views on Balancing Research with Privacy and Protection

  2009cited by this paper
• Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays

  2008cited by this paper
• Genetics. Genomic research and human subject privacy.

  2004cited by this paper
• Genomic Research and Human Subject Privacy

  2004cited by this paper

• Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development

  2022cites this paper
• ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

  2021cites this paper
• Informatics Approaches for Harmonized Intelligent Integration of Stem Cell Research

  2020cites this paper
• A pathway for attesting ethical provenance of cell lines: Lessons from the European human pluripotent stem cell registry (hPSCreg).

  2019cites this paper
• Pluripotent Stem Cell Banks

  2018cites this paper
• The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks

  2017cites this paper
• Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing.

  2016cites this paper
• Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).

  2015cites this paper
• Identifiability and privacy in pluripotent stem cell research.

  2014cites this paper
• The DISCUSS Project: Induced Pluripotent Stem Cell Lines From Previously Collected Research Biospecimens and Informed Consent: Points to Consider

  2013cites this paper
• Alliances, collaborations and consortia: the International Stem Cell Forum and its role in shaping global governance and policy.

  2012cites this paper
• Disclosure and management of research findings in stem cell research and banking: policy statement.

  2012cites this paper
• Genomic and stem cell policy issues: more alike than different?

  2011cites this paper
• From Banking to International Governance: Fostering Innovation in Stem Cell Research

  2011cites this paper